Factor VIII Antikörper (AA 1451-1550)
-
- Target Alle Factor VIII (F8) Antikörper anzeigen
- Factor VIII (F8) (Coagulation Factor VIII (F8))
-
Bindungsspezifität
- AA 1451-1550
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Factor VIII Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Kreuzreaktivität
- Human, Maus
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human factor VIII
- Isotyp
- IgG
- Top Product
- Discover our top product F8 Primärantikörper
-
-
- Applikationshinweise
-
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
-
IFN-? inhibits osteopontin expression in human decidual stromal cells and can be attenuated by 1?,25-dihydroxyvitamin D3." in: American journal of reproductive immunology (New York, N.Y. : 1989), Vol. 68, Issue 4, pp. 353-61, (2012) (PubMed).
: "Heparanase and vascular endothelial growth factor expression is increased in hypoxia-induced retinal neovascularization." in: Investigative ophthalmology & visual science, Vol. 53, Issue 11, pp. 6810-7, (2012) (PubMed).
: "Suppression of bladder cancer cell tumorigenicity in an athymic mouse model by adenoviral vector-mediated transfer of LRIG1." in: Oncology reports, Vol. 26, Issue 2, pp. 439-46, (2011) (PubMed).
: "Changes in number and biological function of endothelial progenitor cells in hypertension disorder complicating pregnancy." in: Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, Vol. 28, Issue 6, pp. 670-3, (2008) (PubMed).
: "
-
IFN-? inhibits osteopontin expression in human decidual stromal cells and can be attenuated by 1?,25-dihydroxyvitamin D3." in: American journal of reproductive immunology (New York, N.Y. : 1989), Vol. 68, Issue 4, pp. 353-61, (2012) (PubMed).
-
- Target
- Factor VIII (F8) (Coagulation Factor VIII (F8))
- Andere Bezeichnung
- factor 8/F8 (F8 Produkte)
- Synonyme
- fb61d02 antikoerper, wu:fb61d02 antikoerper, Cf-8 antikoerper, Cf8 antikoerper, FVIII antikoerper, AHF antikoerper, DXS1253E antikoerper, F8B antikoerper, F8C antikoerper, HEMA antikoerper, coagulation factor VIIi antikoerper, coagulation factor VIII antikoerper, coagulation factor VIII, procoagulant component antikoerper, f7i antikoerper, F8 antikoerper
- Hintergrund
-
Synonyms: AHF, F8B, F8C, HEMA, FVIII, DXS1253E, Coagulation factor VIII, Antihemophilic factor, Procoagulant component, F8
Background: Factor VIII, along with calcium and phospholipid, acts as a cofactor for factor IXa when it converts factor X to the activated form, factor Xa.
- Gen-ID
- 2157
- UniProt
- P00451
-